Related Experiment Video
Updated: Dec 8, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Risk factors for intracerebral hemorrhage in patients with COVID-19
Kara R Melmed1,2, Meng Cao3, Siddhant Dogra4
1Department of Neurology, New York University Langone Health, New York, NY, USA. kara.melmed@nyulangone.org.
Insights
Therapeutic anticoagulation significantly increases the risk of intracerebral hemorrhage (ICH) in patients with coronavirus disease (COVID-19). This finding highlights the need for careful consideration of anticoagulation strategies in COVID-19 patients to mitigate ICH risk.
Area of Science:
- Neurology
- Infectious Diseases
- Critical Care Medicine
Background:
- Intracerebral hemorrhage (ICH) is a severe complication of coronavirus disease (COVID-19).
- Identifying risk factors for ICH in COVID-19 patients is crucial for management.
- Previous studies have not fully elucidated the specific risks associated with COVID-19 and ICH.
Purpose of the Study:
- To assess risk factors associated with intracerebral hemorrhage (ICH) in patients with COVID-19.
- To determine the association between anticoagulation therapy and ICH in this patient population.
- To evaluate the impact of ICH on mortality in COVID-19 patients.
Main Methods:
- Retrospective cohort study of adult COVID-19 patients admitted between March 1 and April 27, 2020.
- Inclusion criteria: positive COVID-19 test, primary non-traumatic intracranial hemorrhage or hemorrhagic conversion of ischemic stroke on neuroimaging.
- Exclusion criteria: intracranial procedures, malignancy, vascular malformation. Regression models used to analyze risk factors and mortality.
Main Results:
- Out of 416 eligible COVID-19 patients, 33 (7.9%) experienced ICH.
- Univariate analysis showed older age, non-Caucasian race, respiratory failure requiring mechanical ventilation, and therapeutic anticoagulation were associated with ICH.
- Adjusted regression models revealed anticoagulation use increased ICH risk five-fold (OR 5.26, p < 0.001).
- ICH was associated with increased mortality (adjusted OR 2.6, p < 0.05).
Conclusions:
- Therapeutic anticoagulation is a significant risk factor for intracerebral hemorrhage in COVID-19 patients.
- Intracerebral hemorrhage is linked to increased mortality in the COVID-19 population.
- Further research is needed to understand mechanisms and develop prevention strategies for ICH in COVID-19.
Abstract:
Intracerebral hemorrhage (ICH) can be a devastating complication of coronavirus disease (COVID-19). We aimed to assess risk factors associated with ICH in this population. We performed a retrospective cohort study of adult patients admitted to NYU Langone Health system between March 1 and April 27 2020 with a positive nasopharyngeal swab polymerase chain reaction test result and presence of primary nontraumatic intracranial hemorrhage or hemorrhagic conversion of ischemic stroke on neuroimaging. Patients with intracranial procedures, malignancy, or vascular malformation were excluded. We used regression models to estimate odds ratios and 95% confidence intervals (OR, 95% CI) of the association between ICH and covariates. We also used regression models to determine association between ICH and mortality. Among 3824 patients admitted with COVID-19, 755 patients had neuroimaging and 416 patients were identified after exclusion criteria were applied. The mean (standard deviation) age was 69.3 (16.2), 35.8% were women, and 34.9% were on therapeutic anticoagulation. ICH occurred in 33 (7.9%) patients. Older age, non-Caucasian race, respiratory failure requiring mechanical ventilation, and therapeutic anticoagulation were associated with ICH on univariate analysis (p < 0.01 for each variable). In adjusted regression models, anticoagulation use was associated with a five-fold increased risk of ICH (OR 5.26, 95% CI 2.33-12.24, p < 0.001). ICH was associated with increased mortality (adjusted OR 2.6, 95 % CI 1.2-5.9). Anticoagulation use is associated with increased risk of ICH in patients with COVID-19. Further investigation is required to elucidate underlying mechanisms and prevention strategies in this population.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Factors affecting Blood pressure
Physiological Factors:
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

